Oak Point Partners, Inc. acquired the remnant assets of the Savient Pharmaceuticals, Inc. Bankruptcy Estate in May 2014.

On October 14, 2013, Savient Pharmaceuticals, Inc. filed a chapter 11 petition in the United States Bankruptcy Court for the District of Delaware, assigned Case No. 13-12680.  Thereafter, a trustee was charged with winding down the estate for the benefit of creditors.  Oak Point Partners, Inc. acquired the remnant assets of the Savient Pharmaceuticals, Inc. Bankruptcy Estate in May 2014.

About Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals was a specialty biopharmaceutical company.

Savient Pharmaceuticals also operated as Bio-Technology General Corp and Gynex.

The former headquarters of Savient Pharmaceuticals was in Bridgewater, New Jersey.

Funds or Proceeds owed to Savient Pharmaceuticals, Inc.
Inquiries regarding overpayments, refunds, unclaimed or undeliverable funds or proceeds owed to Savient Pharmaceuticals, Bio-Technology General Corp, or Gynex may be directed to Oak Point Partners at:

Oak Point Partners, Inc.
P.O. Box 1033
Northbrook, IL 60065-1033
remnants@oakpointpartners.com

For questions or additional information please contact Janice Alwin at 847-577-1374. Requests for reasonable referral or finder fees will be considered.

About Oak Point Partners
Oak Point Partners is a private investment firm specializing in the purchase of remnant assets. Oak Point Partners has completed purchases of the remaining known and unknown assets in hundreds of Chapter 11 and Chapter 7 bankruptcy cases. Purchases include assets of Champion Enterprises, EarthShell Corporation, and Insuramericorp. Click here for a listing of Oak Point owned estates.

Disclaimer
The information contained in this website is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability with respect to the information contained or services offered on the website for any purpose.